Frontlight ResearchEarly access
Colorectal cancer trials in United States
551 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleEvaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
- Where
- Chapel Hill, Chicago, Duarte, Miami, New Orleans, Overland Park, Salt Lake City, Santa Monica, Tampa
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- Delcath Systems Inc.
See details and how to joinNCT06607458 - No phaseNot yet taking people in United StatesThe PharmFIT Study
- Where
- Chapel Hill, Seattle
- Age
- 18 years to 99 years
- People
- 1,500
- Run by
- UNC Lineberger Comprehensive Cancer Center
See details and how to joinNCT06656936 - Phase 1/2Not yet taking people in United StatesFirst-in-human Trial of STC-1010, an Immunotherapy, in Patients With Unresectable Locally Advanced or Metastatic Colorectal Cancer
- Where
- Baltimore
- Age
- 18 years to 75 years
- People
- 90 worldwide
- Run by
- Brenus Pharma
See details and how to joinNCT06934538 - No phaseNot yet taking people in United StatesLife Expectancy-informed Colorectal Cancer Screening
- Where
- Cleveland
- Age
- 76 years and over
- People
- 15,000
- Run by
- Kathryn Martinez
See details and how to joinNCT07141901 - Phase 2Taking peopleStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer
- Where
- Boston, Charlottesville, North Haven, Sioux Falls, St Louis
- Age
- 18 years and over
- People
- 170 worldwide
- Run by
- Gilead Sciences
See details and how to joinNCT07527858 - Phase 1/2Taking peoplePhase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- Where
- Duarte, Fairfax, Santa Monica
- Age
- 18 years and over
- People
- 164
- Run by
- BigHat Biosciences, Inc.
See details and how to joinNCT07529808 - Phase 1/2Taking peopleA Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)
- Where
- Aurora, Durham, Houston, Los Alamitos, Los Angeles, Madison, New York, San Antonio, Santa Monica, Wenatchee, Whittier
- Age
- 18 years and over
- People
- 346 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06885034 - Phase 3Taking peopleA Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
- Where
- Abilene, Aurora, Blacksburg, Chicago, Cincinnati, Duarte, Durham, East Brunswick, Goodyear, Houston, Kansas City, Lake Success, New Haven, Newnan, Portland, Seattle, Springdale, Tampa
- Age
- 18 years and over
- People
- 990 worldwide
- Run by
- AbbVie
See details and how to joinNCT07525206 · EU 2025-521712-19-00 - Phase 2Taking peopleNeoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- Where
- Chicago, Corona, Duarte, Goodyear, Huntington Beach, Irvine, Long Beach, Newnan, South Pasadena, Upland, Zion
- Age
- 18 years and over
- People
- 100
- Run by
- City of Hope Medical Center
See details and how to joinNCT07595874 - No phaseNot yet taking people in United StatesIncreasing Breast and Colorectal Cancer Screening in the Community
- Where
- New York
- Age
- 45 years to 75 years
- People
- 80
- Run by
- Icahn School of Medicine at Mount Sinai
See details and how to joinNCT07748377 - Phase 2Taking peoplePDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05286814 - No phaseTaking peopleColorectal Cancer Screening in the Homeless
- Where
- Washington D.C.
- Age
- 45 years to 75 years
- People
- 588
- Run by
- George Washington University
See details and how to joinNCT07220018 - Phase 1Taking peopleA Study to Assess Adverse Events, Change in Disease Activity and How Intravenous ABBV-253 Moves Through the Body in Adult Participants With Advanced Solid Tumors
- Where
- Grand Rapids, Huntersville, Irving
- Age
- 18 years and over
- People
- 130
- Run by
- AbbVie
See details and how to joinNCT07807956 · EU 2026-526097-17-00 - Phase 1Taking peopleTesting for Safety and Colorectal Cancer Preventive Effects of ONC201
- Where
- Ann Arbor, Cleveland, Columbus, Providence, St Louis
- Age
- 18 years and over
- People
- 36
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05630794 - Phase 1/2Taking peopleDose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
- Where
- Boston, Denver, Houston, Miami, Nashville, San Antonio
- Age
- 18 years and over
- People
- 330
- Run by
- ModeX Therapeutics, An OPKO Health Company
See details and how to joinNCT06239194 - Phase 1/2Taking peopleFluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in Patients With Locally Advanced or Recurrent Colorectal Cancer
- Where
- Buffalo
- Age
- 18 years and over
- People
- 21
- Run by
- Roswell Park Cancer Institute
See details and how to joinNCT06307548 - Phase 1Taking peopleTesting the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
- Where
- Cincinnati, Irvine, Orange, Pittsburgh, The Bronx, West Chester
- Age
- 18 years and over
- People
- 39
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06654037 - Phase 2Taking peopleA Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
- Where
- Charleston, Fairfax, Lancaster, Miami Beach, Nashville, New Brunswick, New Haven, New York, Orlando, Philadelphia, Pittsburgh, San Antonio, Seattle
- Age
- 18 years and over
- People
- 120
- Run by
- Criterium, Inc.
See details and how to joinNCT06992258 - Phase 1/2Taking peopleA Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
- Where
- Denver, Detroit, New York, Orlando
- Age
- 18 years and over
- People
- 245 worldwide
- Run by
- BioNTech SE
See details and how to joinNCT07186842 · EU 2025-522613-26-00 - Phase 2Not yet taking people in United StatesA Study of Olomorasib (LY3537982) in Participants With Advanced Colorectal Cancer and a KRAS G12C Mutation
- Where
- Austin, Birmingham, Boston, East Brunswick, Fairfax, Falls Church, Los Angeles, Madison, Orlando
- Age
- 18 years and over
- People
- 50 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07814417 · EU 2026-526138-23-00 - Phase 1Not yet taking people in United StatesMTX-531-001 Phase 1 Study in Advanced Solid Tumors
- Where
- Newport Beach
- Age
- 18 years and over
- People
- 71
- Run by
- MEKanistic Therapeutics, Inc.
See details and how to joinNCT07874880 - Phase 1Taking peopleKO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
- Where
- Boston, Celebration, Columbus, Dallas, Denver, Detroit, Houston, Iowa City, Jacksonville, Los Angeles, Madison, Nashville, New Brunswick, Oklahoma City, Phoenix, Pittsburgh, Rochester, Sarasota, St Louis, Tucson
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- Kura Oncology, Inc.
See details and how to joinNCT06026410 · EU 2024-513285-19-00 - Phase 2Taking peopleMedical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer
- Where
- Saint Louis Park
- Age
- 18 years and over
- People
- 64
- Run by
- HealthPartners Institute
See details and how to joinNCT06605430 - Early phase 1Taking peopleASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer
- Where
- Houston
- Age
- 18 years and over
- People
- 100
- Run by
- M.D. Anderson Cancer Center
See details and how to joinNCT07318389 - Phase 1Taking peopleTCR1188-ABC Cells in KRAS-mutated Cancers
- Where
- Philadelphia
- Age
- 18 years and over
- People
- 30
- Run by
- University of Pennsylvania
See details and how to joinNCT07594067